Epoch is the Total BioDesign company developing natural solutions to unnatural problems. We are designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.
Location: United Kingdom
Employees: 11-50
Total raised: $41.3M
Investors 6
| Date | Name | Website |
| - | The Ventur... | theventure... |
| 25.10.2023 | Plug and P... | plugandpla... |
| 27.08.2022 | TechX | netzerotc.... |
| 25.06.2022 | Amadeus Ca... | amadeuscap... |
| 18.07.2022 | Cambridge ... | cambridgea... |
| - | BoxGroup | boxgroup.c... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 25.03.2026 | - | $12M | Leitmotif |
| 05.03.2025 | Series A | $18.3M | - |
| 22.06.2022 | Seed | $11M | - |
Mentions in press and media 7
| Date | Title | Description |
| 25.03.2026 | Epoch Biodesign raises $12M to bring recycled nylon to scale | Epoch Biodesign, a London-based company developing enzymatic recycling technology, has closed a $12 million strategic funding round with participation from lululemon, KOMPAS VC, Happiness Capital, Extantia, Leitmotif and others. The new inv... |
| 02.10.2025 | Epoch Biodesign to Accelerate Global Scale-Up of Revolutionary Plastic Recycling Technology with Former INVISTA CTO | Jerry Grunewald, previously CTO of the world's largest Nylon 6,6 producer, INVISTA, joins Epoch Biodesign (Epoch) as Senior Advisor Apppointment builds momentum after Epoch’s Series A & it plans to process tens of thousands of tonnes of... |
| 05.03.2025 | Epoch Biodesign: Turning Plastic Waste into Gold | Epoch Biodesign is on a mission. A mission to transform plastic waste into valuable resources. The London-based company recently secured $18.3 million in Series A funding, along with a $1 million grant from the UK government. This funding i... |
| 05.03.2025 | Epoch BioDesign raises $18.3M to transform plastic waste into valuable resources | Epoch BioDesign has raised $18.3 million in Series A to advance its work using enzymes to make recycled plastics cheaper and higher performing than virgin materials. Traditional mechanical recycling struggles with mixed plastics, lowering t... |
| 05.03.2025 | Epoch Biodesign Raises $18.3M in Series A; $1M Grant | Epoch Biodesign, a London, UK-based company using enzymes to make recycled plastics cheaper and higher performing than virgin materials, raised $18.3M in Series A funding, alongside $1M grant from the UK government. The round was led by Ext... |
| 05.03.2025 | Epoch Biodesign raises €17 million to turn the plastic crisis into a circular revolution | Epoch Biodesign, a London-based startup using enzymes to make recycled plastics cheaper and higher performing than virgin materials, today announced it has raised €17 million in Series A capital in an oversubscribed round. The financing rou... |
| 22.06.2022 | Epoch Biodesign Raises $11M in Seed Funding | Epoch Biodesign, a London, UK-based Total BioDesignTM Company, raised $11M in seed funding. The round was led by Lowercarbon Capital, with participation from BoxGroup, Amadeus Capital Partners, MCJ Collective, Zero Carbon capital, VOYAGERS ... |